ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

UBS slashes target price on Novo Nordisk, citing compounders, Eli Lilly threat

Announcement as on 05 August 2025

Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patients
Eli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, reducing mortality and cardiovascular risks. The SURPASS-CVOT trial revealed Mounjaro's superiority over Trulicity, showing improvements
Announcement as on 31 July 2025

Eli Lilly to roll out diabetes medicine in prefilled pen
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The KwikPen offers a convenient, once-weekly administration. It contains four fixed doses. This launch intensifies competition with No
Announcement as on 27 June 2025

Eli Lilly to launch Mounjaro KwikPen for type 2 diabetes in India
Eli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following regulatory approval. This offers a convenient option for adults with type 2 diabetes. Mounjaro, a dual GIP and GLP-1 receptor agon
Announcement as on 26 June 2025

Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand
Eli Lilly's Mounjaro has seen a positive reception in India, capturing significant sales and market interest since its launch in March. The company is prioritizing meeting the growing demand for the diabetes and weight-loss drug in the country, where obesi
Announcement as on 20 June 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 909.2
  • 12Day Average: 919.06
  • 20Day Average: 920.71
  • 50Day Average: 963.4
  • 100Day Average: 1006.86
  • 150Day Average: 963.53
  • 200Day Average: 907.85

LLY Indicators & signals

Indicator MACD (12,26,9)

915.05, 929.53, -14.58
Indicator MACD is in negative zone

Indicator ADX (14)

33.68, 17.8, 35.88
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Fri Apr 2026 883.96 871.73 to 917.06 -3.67% 1.08 times
23 Thu Apr 2026 917.65 911.89 to 930.00 -0.42% 0.9 times
22 Wed Apr 2026 921.48 902.23 to 922.54 2.04% 1.1 times
21 Tue Apr 2026 903.02 881.11 to 913.05 -1.83% 1.71 times
20 Mon Apr 2026 919.90 912.50 to 929.64 -0.77% 0.81 times
17 Fri Apr 2026 927.03 917.80 to 929.99 2.61% 1.37 times
16 Thu Apr 2026 903.43 898.15 to 920.00 -0.18% 0.56 times
15 Wed Apr 2026 905.03 888.03 to 930.00 -1.94% 1.78 times
14 Tue Apr 2026 922.89 915.04 to 939.93 -0.72% 0.52 times
13 Mon Apr 2026 929.55 927.17 to 945.90 -1.07% 0.88 times
10 Fri Apr 2026 939.57 935.54 to 963.94 -1.64% 0.37 times
09 Thu Apr 2026 955.19 939.29 to 963.76 0.2% 0.7 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top